RevMed (RVMD) - Bozor kapitallashuvining balans qiymatiga nisbati
Revolution Medicines (RVMD) kompaniyasining ushbu kunlik narxlar grafigi onkologik terapiya ishlab chiquvchisiga nisbatan bozor kutganlarini aks ettiradi, bunda joriy ko'rsatkich 15.41 darajasida turibdi. Savdolarning yo'qligi va yuqori R&D xarajatlari tufayli kompaniyada foyda va barqaror pul oqimi mavjud emas. Biroq, noyob patentlar raqobatchilarga nisbatan texnologik ustunlikni ta'minlaydi va klinik sinovlarning muvaffaqiyati kelgusida kompaniyaga o'z dori vositalari uchun narxlarni bir tomonlama belgilash imkoniyatini beradi.
%20Kapitallashuvning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvt4kixj.9g-7avve2o&start=20220704&end=20261029&filename=GURU_Markets_-_RVMD_-_Revolution-Medicines_-_Market-Cap-to-Net-Assets-Ratio "RevMed (RVMD) Bozor kapitallashuvining balans qiymatiga nisbati: 04.07.2022 - 29.10.2026 davri uchun | 👁️GURU.Markets👁️")
Revolution Medicines Inc (RVMD) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- aksiya kursi va ekspertlarning narx prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati Revolution Medicines|RVMD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati RevMed|RVMD - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati RevMed|RVMD - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Revolution Medicines
Kompaniyaning har tomonlama tahlili:Revolution Medicines
Revolution Medicines (RVMD) kompaniyasining joriy P/BV koeffitsiyenti bozarning kompaniya intellektual aktivlarini qayta baholashini aks ettiradi, chunki uning kengayish modeli patentlangan onkologik dori vositalarining yuqori marjalariga tayanadi. Ushbu ko'rsatkich biznesning bozor qiymatini uning sof aktivlari bilan solishtiradi, bu esa past narxning qadrsizlanish natijasi ekanligini yoki tizimli kapital yo'qotilishining belgisi ekanligini aniqlash imkonini beradi, bu esa biotexnologiya sektorida xavflarni baholash uchun juda muhimdir.
Revolution Medicines kimlar bilan raqobatlashadi
ONC: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati HALO|AAPG (Ascentage Pharma) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati CG Oncology Inc (CGON)|Bozor kapitallashuvining balans qiymatiga nisbati URGN|Bozor kapitallashuvining balans qiymatiga nisbati Bicara Corp (BCAX)|Bozor qiymatining balans qiymatiga nisbati Personalis, Inc. PSNL|ERAS: Kapitallashuvning balans qiymatiga nisbati|Delcath Systems - Bozor kapitallashuvining balans qiymatiga nisbati|Y-mAbs Therapeutics Inc (YMAB) - Kapitallashuvning sof aktivlarga nisbati|AURA: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Candel Therapeutics, Inc. (CADL)|Bozor qiymatining balans qiymatiga nisbati Accuray Incorporated|SLS: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati ACTU (Actuate Therapeutics)|CTOR (Citius Oncology Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati HURA (TuHURA Biosciences)|TARA - Kapitallashuvning sof aktivlarga nisbati|FATE: Kapitallashuvning sof aktivlarga nisbati|WHWK - Bozor kapitallashuvining balans qiymatiga nisbati|tscan.com (TCRX) - Bozor qiymatining balans qiymatiga nisbati|Champions Oncology, Inc. - Balans qiymatiga nisbatan bozor qiymati|XBIT (XBiotech Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti CEL-SCI Corp CVM|Bozor qiymatining balans qiymatiga nisbati OS Therapies Incorporated (OSTX)|RADX (Radiopharm Theranostics Ltd) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati ARTV (Artiva Biotherapeutics)|Adlai Nortye Ltd (ANL) - Bozor qiymatining balans qiymatiga koeffitsiyenti|VERU: Kapitallashuvning sof aktivlarga nisbati|TPST: Bozor qiymatining balans qiymatiga nisbati|xiliotx.com (XLO) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Renovaro (RENB)|Bozor qiymatining balans qiymatiga nisbati Mural Oncology PLC|Bozor qiymatining balans qiymatiga nisbati KAPA|Kapitallashuvning sof aktivlarga nisbati OKUR (OnKure Therapeutics Inc)|Bozor kapitallashuvining balans qiymatiga nisbati w2.cytomed.sg (GDTC)|Curis - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga multiplikatori APLM (Apollomics Inc.)|Tharimmune - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Advanced Biomed Inc ADVB|Genprex, Inc (GNPX) - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Calidi Biotherapeutics, Inc. (CLDI)|Bozor qiymatining balans qiymatiga nisbati Sunshine Biopharma|Kapitallashuvning balans qiymatiga nisbati XBIO (Xenetic Bio)|Kapitallashuvning sof aktivlarga nisbati SLRX (Salarius Pharmaceuticals, Inc.)|PPBT (Purple Biotech Ltd) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati American Oncology Network, Inc. AONC|BGNE - Kapitallashuvning sof aktivlarga nisbati|Checkpoint Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Elevation Oncology Inc.|ICAD: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati IKNA|NTBL (Notable Labs Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Viracta (VIRX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati MOR|Kapitallashuvning sof aktivlarga nisbati nayabiosciences.com NAYA|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV (Ascentage Pharma)